Literature DB >> 22156155

Review of indications and practices of vena caval filters at a large university hospital.

Robert J Meisner1, Nicos Labropoulos, Antonios P Gasparis, Jenica Lampl, Min Xu, Apostolos K Tassiopoulos.   

Abstract

BACKGROUND: Vena caval filter (VCF) use has been increasing in recent years. Prophylactic VCF placement has been applied liberally in high-risk patients.
METHODS: Consecutive patients with VCF placement over a 2-year period at a university hospital were reviewed.
RESULTS: A total of 244 patients underwent VCF placement in 2 years. Of all, 54% of the patients had the VCF placed for an absolute indication, 14% for a relative indication, and 32% for prophylaxis. Only 14 (9%) of the retrievable filters were removed. Eight patients had a complication of VCF placement; there were no complications of filter retrieval. Vena caval filter placement for prophylaxis alone was 57% from the division of trauma and surgical critical care, 18.3% from interventional radiology department, and 5.2% from the division of vascular surgery.
CONCLUSIONS: This study indicates that many VCFs are placed for prophylaxis. A low percentage of VCFs was retrieved. This may be the practice at many other large university-based hospitals, necessitating strategies for reducing their placement.

Entities:  

Mesh:

Year:  2011        PMID: 22156155     DOI: 10.1177/1538574411422274

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  Retrospective analysis of outcomes following inferior vena cava (IVC) filter placement in a managed care population.

Authors:  Damian Everhart; Jamieson Vaccaro; Karen Worley; Teresa L Rogstad; Mitchel Seleznick
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

2.  Current Status of the Retrieval Rate of Retrievable Vena Cava Filters in a Tertiary Referral Center in Korea.

Authors:  Hyeongmin Park; Ahram Han; Chanjoong Choi; Sang-Il Min; Jongwon Ha; In Mok Jung; Taeseung Lee; Hyo-Cheol Kim; Hwan Joon Jae; Seung-Kee Min
Journal:  Vasc Specialist Int       Date:  2014-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.